Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.
<h4>Background</h4>Topoisomerase I (Top1) is the target of Top1 inhibitor chemotherapy. The TOP1 gene, located at 20q12-q13.1, is frequently detected at elevated copy numbers in colorectal cancer (CRC). The present study explores the mechanism, frequency and prognostic impact of TOP1 gen...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/322a7ecea97547bfa7fddff12c3549c1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:322a7ecea97547bfa7fddff12c3549c1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:322a7ecea97547bfa7fddff12c3549c12021-11-18T07:50:26ZMechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.1932-620310.1371/journal.pone.0060613https://doaj.org/article/322a7ecea97547bfa7fddff12c3549c12013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23577133/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Topoisomerase I (Top1) is the target of Top1 inhibitor chemotherapy. The TOP1 gene, located at 20q12-q13.1, is frequently detected at elevated copy numbers in colorectal cancer (CRC). The present study explores the mechanism, frequency and prognostic impact of TOP1 gene aberrations in stage III CRC and how these can be detected by fluorescent in situ hybridization (FISH).<h4>Methods</h4>Nine CRC cell line metaphase spreads were analyzed by FISH with a TOP1 probe in combination with a reference probe covering either the centromeric region of chromosome 20 (CEN-20) or chromosome 2 (CEN-2). Tissue sections from 154 chemonaive stage III CRC patients, previously studied with TOP1/CEN-20, were analyzed with TOP1/CEN-2. Relationships between biomarker status and overall survival (OS), time to recurrence (TTR) in CRC and time to local recurrence (LR; rectal cancer only) were determined.<h4>Results</h4>TOP1 aberrations were observed in four cell line metaphases. In all cell lines CEN-2 was found to reflect chromosomal ploidy levels and therefore the TOP1/CEN-2 probe combination was selected to identify TOP1 gene gains (TOP1/CEN-2≥1.5). One hundred and three patients (68.2%) had TOP1 gain, of which 15 patients (14.6%) harbored an amplification (TOP1/CEN-20≥2.0). TOP1 gene gain did not have any association with clinical endpoints, whereas TOP1 amplification showed a non-significant trend towards longer TTR (multivariate HR: 0.50, p = 0.08). Once amplified cases were segregated from other cases of gene gain, non-amplified gene increases (TOP1/CEN-2≥1.5 and TOP1/CEN-20<2.0) showed a trend towards shorter TTR (univariate HR: 1.57, p = 0.07).<h4>Conclusions</h4>TOP1 gene copy number increase occurs frequently in stage III CRC in a mechanism that often includes CEN-20. Using CEN-2 as a measurement for tumor ploidy levels, we were able to discriminate between different mechanisms of gene gain, which appeared to differ in prognostic impact. TOP1 FISH guidelines have been updated.David Hersi SmithIb Jarle ChristensenNiels Frank JensenBo MarkussenMaria Unni RømerSune Boris NygårdSven MüllerHans Jørgen NielsenNils BrünnerKirsten Vang NielsenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 4, p e60613 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q David Hersi Smith Ib Jarle Christensen Niels Frank Jensen Bo Markussen Maria Unni Rømer Sune Boris Nygård Sven Müller Hans Jørgen Nielsen Nils Brünner Kirsten Vang Nielsen Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| description |
<h4>Background</h4>Topoisomerase I (Top1) is the target of Top1 inhibitor chemotherapy. The TOP1 gene, located at 20q12-q13.1, is frequently detected at elevated copy numbers in colorectal cancer (CRC). The present study explores the mechanism, frequency and prognostic impact of TOP1 gene aberrations in stage III CRC and how these can be detected by fluorescent in situ hybridization (FISH).<h4>Methods</h4>Nine CRC cell line metaphase spreads were analyzed by FISH with a TOP1 probe in combination with a reference probe covering either the centromeric region of chromosome 20 (CEN-20) or chromosome 2 (CEN-2). Tissue sections from 154 chemonaive stage III CRC patients, previously studied with TOP1/CEN-20, were analyzed with TOP1/CEN-2. Relationships between biomarker status and overall survival (OS), time to recurrence (TTR) in CRC and time to local recurrence (LR; rectal cancer only) were determined.<h4>Results</h4>TOP1 aberrations were observed in four cell line metaphases. In all cell lines CEN-2 was found to reflect chromosomal ploidy levels and therefore the TOP1/CEN-2 probe combination was selected to identify TOP1 gene gains (TOP1/CEN-2≥1.5). One hundred and three patients (68.2%) had TOP1 gain, of which 15 patients (14.6%) harbored an amplification (TOP1/CEN-20≥2.0). TOP1 gene gain did not have any association with clinical endpoints, whereas TOP1 amplification showed a non-significant trend towards longer TTR (multivariate HR: 0.50, p = 0.08). Once amplified cases were segregated from other cases of gene gain, non-amplified gene increases (TOP1/CEN-2≥1.5 and TOP1/CEN-20<2.0) showed a trend towards shorter TTR (univariate HR: 1.57, p = 0.07).<h4>Conclusions</h4>TOP1 gene copy number increase occurs frequently in stage III CRC in a mechanism that often includes CEN-20. Using CEN-2 as a measurement for tumor ploidy levels, we were able to discriminate between different mechanisms of gene gain, which appeared to differ in prognostic impact. TOP1 FISH guidelines have been updated. |
| format |
article |
| author |
David Hersi Smith Ib Jarle Christensen Niels Frank Jensen Bo Markussen Maria Unni Rømer Sune Boris Nygård Sven Müller Hans Jørgen Nielsen Nils Brünner Kirsten Vang Nielsen |
| author_facet |
David Hersi Smith Ib Jarle Christensen Niels Frank Jensen Bo Markussen Maria Unni Rømer Sune Boris Nygård Sven Müller Hans Jørgen Nielsen Nils Brünner Kirsten Vang Nielsen |
| author_sort |
David Hersi Smith |
| title |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| title_short |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| title_full |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| title_fullStr |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| title_full_unstemmed |
Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. |
| title_sort |
mechanisms of topoisomerase i (top1) gene copy number increase in a stage iii colorectal cancer patient cohort. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/322a7ecea97547bfa7fddff12c3549c1 |
| work_keys_str_mv |
AT davidhersismith mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT ibjarlechristensen mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT nielsfrankjensen mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT bomarkussen mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT mariaunnirømer mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT suneborisnygard mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT svenmuller mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT hansjørgennielsen mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT nilsbrunner mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort AT kirstenvangnielsen mechanismsoftopoisomeraseitop1genecopynumberincreaseinastageiiicolorectalcancerpatientcohort |
| _version_ |
1718422843219247104 |